☰

Kathy A. Steece-Collier, Ph.D. - Publications

Affiliations: 
Translational Science & Molecular Medicine Michigan State University, East Lansing, MI 
Area:
Parkinson's disease / dyskinesias / synaptic reorganization
Tree Info Grants Similar researchers PubMed Report error

62 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Mercado NM, Szarowicz C, Stancati JA, Sortwell CE, Boezwinkle SA, Collier TJ, Caulfield ME, Steece-Collier K. Advancing age and the rs6265 BDNF SNP are permissive to graft-induced dyskinesias in parkinsonian rats. Npj Parkinson's Disease. 10: 163. PMID 39179609 DOI: 10.1038/s41531-024-00771-6  0.793
2024 Steece-Collier K, Mercado N, Szarowicz C, Stancati J, Sortwell C, Boezwinkle S, Collier T, Caulfield M. Advancing Age and the rs6265 BDNF SNP are Permissive to Graft-induced Dyskinesias in Parkinsonian Rats. Research Square. PMID 38746088 DOI: 10.21203/rs.3.rs-4243843/v1  0.752
2024 Stoll AC, Kemp CJ, Patterson JR, Howe JW, Steece-Collier K, Luk KC, Sortwell CE, Benskey MJ. Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions. Neurobiology of Disease. 106411. PMID 38228253 DOI: 10.1016/j.nbd.2024.106411  0.754
2024 Patterson JR, Kochmanski J, Stoll AC, Kubik M, Kemp CJ, Duffy MF, Thompson K, Howe JW, Cole-Strauss A, Kuhn NC, Miller KM, Nelson S, Onyekpe CU, Beck JS, Counts SE, ... ... Steece-Collier K, et al. Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils. Npj Parkinson's Disease. 10: 7. PMID 38172128 DOI: 10.1038/s41531-023-00620-y  0.783
2023 Collier TJ, Begg L, Stancati JA, Mercado NM, Sellnow RC, Sandoval IM, Sortwell CE, Steece-Collier K. Quinpirole inhibits levodopa-induced dyskinesias at structural and behavioral levels: Efficacy negated by co-administration of isradipine. Experimental Neurology. 114522. PMID 37640098 DOI: 10.1016/j.expneurol.2023.114522  0.797
2023 Caulfield ME, Vander Werp MJ, Stancati JA, Collier TJ, Sortwell CE, Sandoval IM, Manfredsson FP, Steece-Collier K. Downregulation of striatal Ca1.3 inhibits the escalation of levodopa-induced dyskinesia in male and female parkinsonian rats of advanced age. Neurobiology of Disease. 181: 106111. PMID 37001610 DOI: 10.1016/j.nbd.2023.106111  0.808
2023 Caulfield ME, Manfredsson FP, Steece-Collier K. The Role of Striatal Cav1.3 Calcium Channels in Therapeutics for Parkinson's Disease. Handbook of Experimental Pharmacology. PMID 36592226 DOI: 10.1007/164_2022_629  0.375
2022 Patterson JR, Hirst WD, Howe JW, Russell CP, Cole-Strauss A, Kemp CJ, Duffy MF, Lamp J, Umstead A, Kubik M, Stoll AC, Vega IE, Steece-Collier K, Chen Y, Campbell AC, et al. Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein. Npj Parkinson's Disease. 8: 61. PMID 35610264 DOI: 10.1038/s41531-022-00322-x  0.758
2021 Caulfield ME, Stancati JA, Steece-Collier K. Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease. Journal of Visualized Experiments : Jove. PMID 34723950 DOI: 10.3791/62970  0.406
2021 Cole TA, Zhao H, Collier TJ, Sandoval I, Sortwell CE, Steece-Collier K, Daley BF, Booms A, Lipton J, Welch M, Berman M, Jandreski L, Graham D, Weihofen A, Celano S, et al. α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease. Jci Insight. 6. PMID 33682798 DOI: 10.1172/jci.insight.135633  0.806
2021 Miller KM, Patterson JR, Kochmanski J, Kemp CJ, Stoll AC, Onyekpe CU, Cole-Strauss A, Steece-Collier K, Howe JW, Luk KC, Sortwell CE. Striatal afferent BDNF is disrupted by synucleinopathy and partially restored by STN DBS. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33472823 DOI: 10.1523/JNEUROSCI.1952-20.2020  0.777
2020 Mercado NM, Stancati JA, Sortwell CE, Mueller RL, Boezwinkle SA, Duffy MF, Fischer DL, Sandoval IM, Manfredsson FP, Collier TJ, Steece-Collier K. The BDNF Val66Met polymorphism (rs6265) enhances dopamine neuron graft efficacy and side-effect liability in rs6265 knock-in rats. Neurobiology of Disease. 105175. PMID 33188920 DOI: 10.1016/j.nbd.2020.105175  0.81
2020 Bartlett MJ, Flores AJ, Ye T, Smidt SI, Dollish HK, Stancati JA, Farrell DC, Parent KL, Doyle KP, Besselsen DG, Heien ML, Cowen SL, Steece-Collier K, Sherman SJ, Falk T. Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia. Experimental Neurology. 113413. PMID 32717354 DOI: 10.1016/J.Expneurol.2020.113413  0.456
2020 Steece-Collier K, Collier TJ, Lipton JW, Stancati JA, Winn ME, Cole-Strauss A, Sellnow R, Conti MM, Mercado NM, Nillni EA, Sortwell CE, Manfredsson FP, Bishop C. Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in fisher 344 vs. Lewis hemiparkinsonian rats. Experimental Neurology. 113327. PMID 32387398 DOI: 10.1016/J.Expneurol.2020.113327  0.818
2020 Sellnow RC, Steece-Collier K, Altwal F, Sandoval IM, Kordower JH, Collier TJ, Sortwell CE, West AR, Manfredsson FP. Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 32238479 DOI: 10.1523/Jneurosci.2936-19.2020  0.84
2019 Collier TJ, Sortwell CE, Mercado NM, Steece-Collier K. Cell therapy for Parkinson's disease: Why it doesn't work every time. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31234239 DOI: 10.1002/Mds.27742  0.825
2019 Steece-Collier K, Stancati JA, Collier NJ, Sandoval IM, Mercado NM, Sortwell CE, Collier TJ, Manfredsson FP. Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31002755 DOI: 10.1002/Mds.27695  0.804
2019 Sellnow RC, Newman JH, Chambers N, West AR, Steece-Collier K, Sandoval IM, Benskey MJ, Bishop C, Manfredsson FP. Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia. Acta Neuropathologica Communications. 7: 8. PMID 30646956 DOI: 10.1186/S40478-018-0653-7  0.522
2017 Fischer DL, Manfredsson FP, Kemp CJ, Cole-Strauss A, Lipton JW, Duffy MF, Polinski NK, Steece-Collier K, Collier TJ, Gombash SE, Buhlinger DJ, Sortwell CE. Subthalamic Nucleus Deep Brain Stimulation Does Not Modify the Functional Deficits or Axonopathy Induced by Nigrostriatal α-Synuclein Overexpression. Scientific Reports. 7: 16356. PMID 29180681 DOI: 10.1038/S41598-017-16690-X  0.818
2017 Fischer DL, Kemp CJ, Cole-Strauss A, Polinski NK, Paumier KL, Lipton JW, Steece-Collier K, Collier TJ, Buhlinger DJ, Sortwell CE. Subthalamic Nucleus Deep Brain Stimulation Employs TrkB Signaling for Neuroprotection and Functional Restoration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28607168 DOI: 10.1523/Jneurosci.2060-16.2017  0.818
2016 Mercado NM, Collier TJ, Freeman T, Steece-Collier K. Repairing the Aged Parkinsonian Striatum: Lessons from the Lab and Clinic. Journal of Clinical & Cellular Immunology. 7. PMID 28111608 DOI: 10.4172/2155-9899.1000476  0.704
2016 Polinski NK, Manfredsson FP, Benskey MJ, Fischer DL, Kemp CJ, Steece-Collier K, Sandoval IM, Paumier KL, Sortwell CE. Impact of age and vector construct on striatal and nigral transgene expression. Molecular Therapy. Methods & Clinical Development. 3: 16082. PMID 27933309 DOI: 10.1038/Mtm.2016.82  0.766
2016 Collier TJ, Redmond DE, Steece-Collier K, Lipton JW, Manfredsson FP. Is Alpha-Synuclein Loss-of-Function a Contributor to Parkinsonian Pathology? Evidence from Non-human Primates. Frontiers in Neuroscience. 10: 12. PMID 26858591 DOI: 10.3389/Fnins.2016.00012  0.773
2015 Divito CB, Steece-Collier K, Case DT, Williams SP, Stancati JA, Zhi L, Rubio ME, Sortwell CE, Collier TJ, Sulzer D, Edwards RH, Zhang H, Seal RP. Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and l-Dopa-Mediated Dyskinesias in a Model of Parkinson's Disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 14983-99. PMID 26558771 DOI: 10.1523/Jneurosci.2124-15.2015  0.802
2015 Madhavan L, Daley BF, Davidson BL, Boudreau RL, Lipton JW, Cole-Strauss A, Steece-Collier K, Collier TJ. Sonic Hedgehog Controls the Phenotypic Fate and Therapeutic Efficacy of Grafted Neural Precursor Cells in a Model of Nigrostriatal Neurodegeneration. Plos One. 10: e0137136. PMID 26340267 DOI: 10.1371/Journal.Pone.0137136  0.779
2015 Fischer DL, Collier TJ, Cole-Strauss A, Wohlgenant SL, Lipton JW, Steece-Collier K, Manfredsson FP, Kemp CJ, Sortwell CE. High-Frequency Stimulation of the Rat Entopeduncular Nucleus Does Not Provide Functional or Morphological Neuroprotection from 6-Hydroxydopamine. Plos One. 10: e0133957. PMID 26222442 DOI: 10.1371/Journal.Pone.0133957  0.829
2015 Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, ... ... Steece-Collier K, et al. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. Progress in Neurobiology. PMID 26209473 DOI: 10.1016/J.Pneurobio.2015.07.002  0.36
2015 Paumier KL, Luk KC, Manfredsson FP, Kanaan NM, Lipton JW, Collier TJ, Steece-Collier K, Kemp CJ, Celano S, Schulz E, Sandoval IM, Fleming S, Dirr E, Polinski NK, Trojanowski JQ, et al. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiology of Disease. 82: 185-199. PMID 26093169 DOI: 10.1016/J.Nbd.2015.06.003  0.813
2015 Kanaan NM, Collier TJ, Cole-Strauss A, Grabinski T, Mattingly ZR, Winn ME, Steece-Collier K, Sortwell CE, Manfredsson FP, Lipton JW. The longitudinal transcriptomic response of the substantia nigra to intrastriatal 6-hydroxydopamine reveals significant upregulation of regeneration-associated genes. Plos One. 10: e0127768. PMID 25992874 DOI: 10.1371/Journal.Pone.0127768  0.796
2015 Collier TJ, O'Malley J, Rademacher DJ, Stancati JA, Sisson KA, Sortwell CE, Paumier KL, Gebremedhin KG, Steece-Collier K. Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration. Neurobiology of Disease. 77: 191-203. PMID 25771169 DOI: 10.1016/J.Nbd.2015.03.005  0.834
2015 Polinski NK, Gombash SE, Manfredsson FP, Lipton JW, Kemp CJ, Cole-Strauss A, Kanaan NM, Steece-Collier K, Kuhn NC, Wohlgenant SL, Sortwell CE. Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrain. Neurobiology of Aging. 36: 1110-20. PMID 25457558 DOI: 10.1016/J.Neurobiolaging.2014.07.047  0.806
2015 Paumier KL, Sortwell CE, Madhavan L, Terpstra B, Celano SL, Green JJ, Imus NM, Marckini N, Daley B, Steece-Collier K, Collier TJ. Chronic amitriptyline treatment attenuates nigrostriatal degeneration and significantly alters trophic support in a rat model of parkinsonism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 874-83. PMID 25267343 DOI: 10.1038/Npp.2014.262  0.831
2015 Polinski NK, Congdon L, Luke Fischer D, Manfredsson FP, Benskey M, Kemp C, Kuhn NC, Cole-Strauss A, Steece-Collier K, Paumier KL, Lipton JW, Sortwell CE. 715. Impact of Aging on Recombinant Adeno-Associated and Lentiviral Vector Transduction Efficiency in the Rat Nigrostriatal and Striatonigral Systems Molecular Therapy. 23: S285. DOI: 10.1016/S1525-0016(16)34324-6  0.817
2015 Sellnow RC, Steece-Collier K, Kanaan NM, Sortwell CE, Collier TJ, Cole-Strauss A, Lipton JW, Manfredsson FP. 709. rAAV-Mediated Regulation of Striatal Nurr1 Expression Alters Development and Severity of Levodopa-Induced Dyskinesias in the 6-OHDA Rat Model of Parkinson's Disease Molecular Therapy. 23: S282-S283. DOI: 10.1016/S1525-0016(16)34318-0  0.828
2015 Polinski N, Gombash S, Kemp C, Kuhn N, Cole-Strauss A, Wohlgenant S, Kanaan N, Steece-Collier K, Lipton J, Manfredsson F, Sortwell C. Decreased viral vector transducibility in the aged rat midbrain Experimental Gerontology. 68: 102. DOI: 10.1016/J.Exger.2015.01.032  0.739
2013 Zhang Y, Meredith GE, Mendoza-Elias N, Rademacher DJ, Tseng KY, Steece-Collier K. Aberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: involvement of corticostriatal but not thalamostriatal synapses. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 11655-67. PMID 23843533 DOI: 10.1523/Jneurosci.0288-13.2013  0.409
2013 Levine ND, Rademacher DJ, Collier TJ, O'Malley JA, Kells AP, San Sebastian W, Bankiewicz KS, Steece-Collier K. Advances in thin tissue Golgi-Cox impregnation: fast, reliable methods for multi-assay analyses in rodent and non-human primate brain. Journal of Neuroscience Methods. 213: 214-27. PMID 23313849 DOI: 10.1016/J.Jneumeth.2012.12.001  0.561
2012 Steece-Collier K, Rademacher DJ, Soderstrom K. Anatomy of Graft-induced Dyskinesias: Circuit Remodeling in the Parkinsonian Striatum. Basal Ganglia. 2: 15-30. PMID 22712056 DOI: 10.1016/J.Baga.2012.01.002  0.514
2012 Gombash SE, Lipton JW, Collier TJ, Madhavan L, Steece-Collier K, Cole-Strauss A, Terpstra BT, Spieles-Engemann AL, Daley BF, Wohlgenant SL, Thompson VB, Manfredsson FP, Mandel RJ, Sortwell CE. Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine model. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 544-54. PMID 22008908 DOI: 10.1038/Mt.2011.216  0.84
2011 Spieles-Engemann AL, Steece-Collier K, Behbehani MM, Collier TJ, Wohlgenant SL, Kemp CJ, Cole-Strauss A, Levine ND, Gombash SE, Thompson VB, Lipton JW, Sortwell CE. Subthalamic nucleus stimulation increases brain derived neurotrophic factor in the nigrostriatal system and primary motor cortex. Journal of Parkinson's Disease. 1: 123-36. PMID 22328911 DOI: 10.3233/Jpd-2011-11008  0.81
2011 Kordower JH, Dodiya HB, Kordower AM, Terpstra B, Paumier K, Madhavan L, Sortwell C, Steece-Collier K, Collier TJ. Transfer of host-derived α synuclein to grafted dopaminergic neurons in rat. Neurobiology of Disease. 43: 552-7. PMID 21600984 DOI: 10.1016/J.Nbd.2011.05.001  0.832
2010 Spieles-Engemann AL, Behbehani MM, Collier TJ, Wohlgenant SL, Steece-Collier K, Paumier K, Daley BF, Gombash S, Madhavan L, Mandybur GT, Lipton JW, Terpstra BT, Sortwell CE. Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss. Neurobiology of Disease. 39: 105-15. PMID 20307668 DOI: 10.1016/J.Nbd.2010.03.009  0.839
2010 Soderstrom KE, O'Malley JA, Levine ND, Sortwell CE, Collier TJ, Steece-Collier K. Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats. The European Journal of Neuroscience. 31: 478-90. PMID 20105237 DOI: 10.1111/J.1460-9568.2010.07077.X  0.845
2009 Steece-Collier K, Soderstrom KE, Collier TJ, Sortwell CE, Maries-Lad E. Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in parkinsonian rats. The Journal of Comparative Neurology. 515: 15-30. PMID 19399877 DOI: 10.1002/Cne.22037  0.846
2008 Soderstrom KE, Meredith G, Freeman TB, McGuire SO, Collier TJ, Sortwell CE, Wu Q, Steece-Collier K. The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors. Neurobiology of Disease. 32: 229-42. PMID 18672063 DOI: 10.1016/J.Nbd.2008.06.018  0.799
2006 Kordower JH, Kanaan NM, Chu Y, Suresh Babu R, Stansell J, Terpstra BT, Sortwell CE, Steece-Collier K, Collier TJ. Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys. Annals of Neurology. 60: 264-8. PMID 16862579 DOI: 10.1002/Ana.20935  0.803
2006 Soderstrom K, O'Malley J, Steece-Collier K, Kordower JH. Neural repair strategies for Parkinson's disease: insights from primate models. Cell Transplantation. 15: 251-65. PMID 16719060 DOI: 10.3727/000000006783982025  0.432
2006 Maries E, Kordower JH, Chu Y, Collier TJ, Sortwell CE, Olaru E, Shannon K, Steece-Collier K. Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats. Neurobiology of Disease. 21: 165-80. PMID 16095907 DOI: 10.1016/J.Nbd.2005.07.002  0.837
2006 Soderstrom K, Levine N, Sortwell C, Collier T, Steece-Collier K. The role of the immune response in the development of dyskinesias following allografting in rats Experimental Neurology. 198: 590. DOI: 10.1016/J.Expneurol.2006.02.095  0.768
2006 O'Malley J, Lipton J, Pei L, Seroogy K, Levine N, Collier T, Sortwell C, Steece-Collier K. Genetics and dyskinesias: Role of DARPP32 modulation in parkinsonian rats Experimental Neurology. 198: 583-584. DOI: 10.1016/J.Expneurol.2006.02.079  0.723
2005 Ariano MA, Grissell AE, Littlejohn FC, Buchanan TM, Elsworth JD, Collier TJ, Steece-Collier K. Partial dopamine loss enhances activated caspase-3 activity: differential outcomes in striatal projection systems. Journal of Neuroscience Research. 82: 387-96. PMID 16180225 DOI: 10.1002/Jnr.20644  0.705
2003 Steece-Collier K, Collier TJ, Danielson PD, Kurlan R, Yurek DM, Sladek JR. Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1442-54. PMID 14673880 DOI: 10.1002/Mds.10588  0.848
2003 Collier TJ, Steece-Collier K, Kordower JH. Primate models of Parkinson's disease. Experimental Neurology. 183: 258-62. PMID 14552866 DOI: 10.1016/S0014-4886(03)00246-2  0.59
2003 Maries E, Dass B, Collier TJ, Kordower JH, Steece-Collier K. The role of alpha-synuclein in Parkinson's disease: insights from animal models. Nature Reviews. Neuroscience. 4: 727-38. PMID 12951565 DOI: 10.1038/Nrn1199  0.61
2003 Collier TJ, Steece-Collier K, McGuire S, Sortwell CE. Cellular models to study dopaminergic injury responses. Annals of the New York Academy of Sciences. 991: 140-51. PMID 12846983  0.802
2002 Steece-Collier K, Maries E, Kordower JH. Etiology of Parkinson's disease: Genetics and environment revisited Proceedings of the National Academy of Sciences of the United States of America. 99: 13972-13974. PMID 12391311 DOI: 10.1073/Pnas.242594999  0.501
1997 Alexander T, Sortwell CE, Sladek CD, Roth RH, Steece-Collier K. Comparison of neurotoxicity following repeated administration of l-dopa, d-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors. Cell Transplantation. 6: 309-15. PMID 9171163 DOI: 10.1016/S0963-6897(97)00031-6  0.783
1995 Steece-Collier K, Yurek DM, Collier TJ, Junn FS, Sladek JR. The detrimental effect of levodopa on behavioral efficacy of fetal dopamine neuron grafts in rats is reversible following prolonged withdrawal of chronic dosing. Brain Research. 676: 404-8. PMID 7614013 DOI: 10.1016/0006-8993(95)00149-K  0.836
1995 Steece-Collier K. Neural grafting in human disease versus animal models: Cautionary notes Behavioral and Brain Sciences. 18: 71-72. DOI: 10.1017/S0140525X00037523  0.367
1992 Felten DL, Felten SY, Steece-Collier K, Date I, Clemens JA. Age-related decline in the dopaminergic nigrostriatal system: The oxidative hypothesis and protective strategies Annals of Neurology. 32: S133-S136. PMID 1510372 DOI: 10.1002/Ana.410320723  0.504
1991 Yurek DM, Steece-Collier K, Collier TJ, Sladek JR. Chronic levodopa impairs the recovery of dopamine agonist-induced rotational behavior following neural grafting. Experimental Brain Research. 86: 97-107. PMID 1684547 DOI: 10.1007/Bf00231044  0.813
1990 Steece-Collier K, Collier TJ, Sladek CD, Sladek JR. Chronic levodopa impairs morphological development of grafted embryonic dopamine neurons. Experimental Neurology. 110: 201-8. PMID 2226699 DOI: 10.1016/0014-4886(90)90031-M  0.767
Show low-probability matches.